Member Info for Mumbo_Jumbo

It does..... shows that they are sloppy scientists.

Roger - how long have you been in this? The sale saga has been going on for 2 years now.... strategies keep changing but one things would be obvious for everyone by now. There is no buyer and there will be no sale but they will rinse and repeat and try to milk this for as long as they can... but that is wearing thin now.

The greater fool theory applies here.

Sang - yes but then he's trying to put a spin on the results... overlooking the fact that there is an anomaly in the design

Phil - I wish I had opened one. But as I said to Ed the other day.... Nasdaq is the place for shorts.

back to the question... why not 17 vs 17?

because they will pay for the bird in hand..... its not rocket science.

Thats why the valuation will be for a specific point in time.

In small sample sizes, this can make a difference in the apparent magnitude of differences that you see. Doesn't make sense to me why you would not have equal population sizes in both groups...

someone care to explain why?

folio and judgemental - so you think Russia will not retaliate with things it has control over? Weapons and natural resources is two things they can turn the screw with.....

We will see what the asset value is at this specific point of time.

Anything below $150 million and we will see proportional hair cut to share price. Personally I think we will get between $80 and $100 million and share price will fall to high single digits.

The US is considering using the law to stop any US designed tech being sold to Russia.
Russia will take over the assets under the guise of national security and not allow its raw materials to be sold to its adversaries. Then watch how inflation rockets ......

Hydrogen - this HNW client is pushing negativity and driving the SP down using this chat board.... you seriously don't believe that do you?

Anthony - and wait till you realise that allowing vaccinated people in P3 was a mistake too.... just a heads up. It happened to Roche and Atea.

Then why did AZN give up on SNG? .... you know why but yet you continue to peddle false hope

will there be 19000 in 3 months time? guess what... omicron would have run through the population. Clearly someone who doesn't understand that market is literally vanishing under your feet. here is something for you ... those 19000 will not be needing SNG.

Look around you, government is opening up and dropping all restrictions... why are they not concerned?

becontrarian - that's what you are hoping for... evidence so far suggests otherwise.

Andy - yes that's the point... prevent people from going into hospital!! Vaccines do that already and these antivirals will be on top.

The cohort for SNG and indeed NRX to be used will be very small. JVT explained that last night and from NRX you should know that is exactly where they have gone for the EUA. I have never mentioned or vouched for NRX here, it is always you. It is a very risky play and not for the feint hearted and I am willing to be open about that, whereas you are pretending that passing the P3 here is almost a certainty. SNG is exactly the same, if it does not pass the P3 it will crater 80-90%. Thats the game with risky plays.

Andy - tell that to valneva….. they did slow and steady but lost the race. The government cancelled the contract as it was too late…

Merck and Pfizer already here….

Ghia - you are talking to someone who has a small punt in NRX, which is actually further ahead in activ3 trial in US. They are going for eua for a small cohort where nothing else works. This is the same cohort sng will eventually be used for if it’s approved. This is the reality, everything else is just a wish list.

I go back to JVT, he’s very clear in where they see this potentially coming in.

TLW - Should this board just be an echo chamber for rampers?

The lemmings should read Ghia's post... the key words he used is "IN TIME". Stop posting false hopes, it will take a long time for it is every approved as a broad spectrum antiviral.

Ghia - I disagree, it did not replicate the P2 in at home setting and will not be used for that. This will not be the first line, but last line therapy and thus restricted to a certain small cohort.

of course Andy, I believe you. Someone who thought EUA was denied last week, when it wasn't.

Omicron will run through the population in few months... that is the point you are seemingly falling to grasp. CDC came out last week and said previous infection is better than vaccination. This is a concerted effort by Governments to pretend that they are doing mitigation but in reality they cannot wait for everyone to get Omicron.

Be prepared for reality check here. Lot of the so called knowledgable people on this board are deliberately letting false hope spread... Like what you and other have spouted ... this will be broad spectrum antiviral!! Not it will not, it will be for a single use case if approved for a very specific and very small cohort.

Maybe I should start a new thread busting these myths one by one.